| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.25 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |